Wellcome Trust / European & Developing Countries Clinical Trials Partnership / The Working Group / HIV / 3M United Kingdom / Vaccines & Microbicides Resource Tracking Working Group / /
Continent
Africa / Europe / /
Country
Switzerland / Germany / Netherlands / Sweden / South Africa / Norway / Belgium / France / United States / Brazil / Canada / Australia / United Kingdom / Spain / /
Currency
USD / /
Event
Funding / FDA Phase / Reorganization / /
IndustryTerm
manufacturing expertise / prevention products / HIV Prevention / prevention applications / universal health insurance / HIV therapeutics / multipurpose prevention technologies / /
immunizations / antiretroviral treatments / Male Circumcision / /
Organization
Development Assistance Committee / National Institute of Health / World Health Organization / Melinda Gates Foundation US / Organization for Economic Co-operation / OECD / UK’s Department for International Development / Welcome Trust US / Global Fund / United States Agency for International Development / Organisation for Economic Co-operation and Development / Melinda Gate Foundation / European Commission / European Union / US Centers for Disease Control and Prevention / /
Person
Francis Collins / /
Position
President / official development assistance / Net Official Development Assistance / director / /
HIV Prevention Research & Development Investment in 2013 In a changing global development, economic, and human rights landscape